Ollie’s Bargain Outlet (NASDAQ:OLLI) had its price objective increased by JPMorgan Chase & Co. from $70.00 to $84.00 in a report released on Tuesday morning. They currently have an overweight rating on the stock.
Several other equities analysts have also recently issued reports
Boeing Co.’s (NYSE: BA) share price added about 2.8% last week to maintain its position as the best performing among the 30 stocks that make up the Dow Jones Industrial Average (DJIA). Shares gained $8.04 last week to boost the year-to-date gain to nearly 89%.
Of the three other stocks closest to Boeing’s yearly gain, Caterpillar Inc. (NYSE: CAT) rose by about 1.9% to a gain of....More>>>
Helios and Matheson’s (HMNY) and MoviePass’ new $9.95 monthly subscription price for MoviePass, while wildly popular with movie fans, is not a sustainable price. Moviepass will run out of cash. Once MoviePass fails, financing in place with Helios and Matheson almost guarantees that Helios and Matheson will be flush with cash while leaving Helios and Matheson’s shareholders footing....More>>>
Walgreens Boots Alliance (WBA) has been through a tumultuous transition period recently. The company’s purchase of stores from Rite Aid (NYSE:RAD) has provided the catalyst for future growth in a sustained way, but the market hasn’t yet fully respected its potential. After the Q4 report a couple of months ago, I said WBA looked cheap, and the stock is up almost....More>>>
(Post Fed Announcement) There’s not much to see here folks. The Federal Reserve appears to have become a master of telegraphing its message to the markets and investors well ahead of announcing its interest-rate “decision” and showcased that again today when it said that it would keep the Federal funds rates in a range of 1% to 1.25%.
Equities analysts forecast that Abbott Laboratories (NYSE:ABT) will report sales of $7.76 billion for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Abbott Laboratories’ earnings, with the lowest sales estimate coming in at $7
Equities analysts forecast that Abbott Laboratories (NYSE:ABT) will report sales of $7.76 billion for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Abbott Laboratories’ earnings, with the lowest sales estimate coming in at $
Since bottoming in April, General Electric (GE) rose 20 percent and continued that uptrend when it announced it will merge GE Transportation with Wabtec (WAB). The deal gives GE a $2.9 billion cash infusion and voting majority ownership in the combined company. Even though asset sales are a natu
Ambow Education (AMBO), which used to be listed on the New York Stock Exchange, will sell 1.5 million ADSs at $3.50 to $4.50 per ADS in the American markets. While it may seem that the offer price is too low, taking into account the previous accounting scandals of Ambow, I dont believe so.